DocuSign (DOCU): Evaluating Valuation as Analyst Optimism Grows Before Next Earnings Report

DocuSign (DOCU) is drawing more attention ahead of its upcoming earnings report, as Wall Street expects the company to deliver higher revenue and earnings compared to the same period last year. The anticipation is fueled by growing demand for its cloud-based digital agreement solutions, as well as continued expansion of its global customer base.

See our latest analysis for DocuSign.

Despite upbeat expectations for its upcoming earnings, DocuSign’s share price tells a more cautious story, with a 1-year total shareholder return of -15.07%. Shares have drifted lower in 2024, now sitting at $68.33. The company’s 3-year total return still comes in strong at over 63%. Recent momentum, however, has faded somewhat, hinting that investors are weighing both past growth and the current valuation as DocuSign looks ahead to its next results.

If you’re curious what other software innovators are doing, it’s a smart time to discover tech and AI-focused stocks. See the full list for free.

Given the recent pullback and lingering optimism around DocuSign’s revenue and earnings growth, investors now face a familiar question: does this dip signal an undervalued opportunity, or has the market already factored in future gains?

Most Popular Narrative: 26.7% Undervalued

The market price of DocuSign closed at $68.33, far below the most popular narrative's fair value estimate of $93.16. This wide gap has investors debating whether the market has missed key growth catalysts or is simply skeptical about future execution.

Rollout and ramp-up of the IAM platform, with AI-native features and deep enterprise system integrations, is unlocking significant upsell opportunities as customers migrate from core eSignature to broader agreement management. This is driving improved ARPU and supporting projections of double-digit future topline growth.

Read the complete narrative.

Want to see the growth recipe behind this outlook? One game-changing product launch could provide a boost to revenue and margin expansion. The full narrative reveals which strategic shift supports this ambitious valuation. Discover the bold bets that analysts are making.

Result: Fair Value of $93.16 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, slowing revenue growth and ongoing margin pressures could challenge expectations for DocuSign’s long-term upside if these headwinds persist.

Find out about the key risks to this DocuSign narrative.

Another View: Multiples Suggest Caution

While analyst forecasts and fair value estimates paint DocuSign as undervalued, the reality through price-to-earnings reveals a different story. At 48.9x, DocuSign’s ratio is notably higher than the US Software industry average of 32x and its peer group at 45.7x, which is far above the fair ratio of 33.9x. This premium suggests investors are paying up for growth, raising questions about valuation risk if expectations are not met. Could future momentum justify this premium, or are returns at risk if the market rethinks its stance?

See what the numbers say about this price — find out in our valuation breakdown.

Build Your Own DocuSign Narrative

If you see the numbers differently or want to dig deeper, you can craft your own perspective in just a few minutes. Do it your way

A great starting point for your DocuSign research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

Looking for More Smart Investment Ideas?

Don’t miss your chance to spot your next top performer with tailored lists that surface real opportunities. Take the next step and upgrade your portfolio by acting on new trends before the crowd does.

• Tap into high-yield potential by checking out these 14 dividend stocks with yields > 3% with reliable payouts over 3% and strong fundamentals that support sustainable growth.
• Uncover companies fueling the future of medicine, as these 30 healthcare AI stocks identifies innovators at the intersection of health and artificial intelligence.
• Spot hidden tech disruptors before they break out. Find these 3565 penny stocks with strong financials already making waves in emerging markets and unrecognized growth niches.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com